Anti-Dnmt2 antibody [ABM1H70]
Be the first to review this product! Submit a review
|
(3 Publications)
Mouse Monoclonal Dnmt2 antibody. Suitable for Flow Cyt, WB and reacts with Human, Mouse samples. Cited in 3 publications. Immunogen corresponding to Recombinant Fragment Protein within Human TRDMT1.
View Alternative Names
DNMT2, TRDMT1, tRNA (cytosine(38)-C(5))-methyltransferase, DNA (cytosine-5)-methyltransferase-like protein 2, DNA methyltransferase homolog HsaIIP, PuMet, Dnmt2, DNA MTase homolog HsaIIP, M.HsaIIP
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-Dnmt2 antibody [ABM1H70] (AB220175)
Flow cytometric analysis of HeLa cells (4% paraformaldehyde-fixed and permeabilized) labeling Dnmt2 with ab220175 at 0.5 μg per 106 cells, followed by goat anti mouse PE conjugated secondary detection (red). Isotype control : green.
- WB
Supplier Data
Western blot - Anti-Dnmt2 antibody [ABM1H70] (AB220175)
All lanes:
Western blot - Anti-Dnmt2 antibody [ABM1H70] (ab220175) at 4 µg/mL
Lane 1:
Jurkat cell lysate
Lane 2:
mouse embryonic liver lysate
Predicted band size: 45 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cancer gene therapy 30:149-162 PubMed36123390
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 13:7989-8002 PubMed34707405
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 11:1932 PubMed32973796
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com